Roux A, Elia A, Hudelist B, Benzakoun J, et al. Prognostic significance of MRI contrast enhancement in newly diagnosed glioblastoma, IDH-wildtype according to WHO 2021 classification. J Neurooncol 2024 Jun 24. doi: 10.1007/s11060-024-04747.
PMID: 38913230